NGVT•benzinga•May 4, 2022 at 09:33 PM

Ingevity Raises Top Ends Of FY22 Sales, Adj. EBITDA Guidance; Sees FY22 Sales $1.525B-$1.65B Vs $1.54B Est., Adj. EBITDA $430M-$470M

No summary available.

Read the full article from the original source for complete details and context.

Article published on May 4, 2022 by benzinga